BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29329784)

  • 1. Regulatory Science - An Underappreciated Component of Translational Research.
    Rouse R; Zineh I; Strauss DG
    Trends Pharmacol Sci; 2018 Mar; 39(3):225-229. PubMed ID: 29329784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives in regulatory science: translational and clinical pharmacology.
    Grillo JA; Huang SM
    Drug Discov Today Technol; 2016; 21-22():67-73. PubMed ID: 27978990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling reproducibility in academic preclinical drug discovery.
    Frye SV; Arkin MR; Arrowsmith CH; Conn PJ; Glicksman MA; Hull-Ryde EA; Slusher BS
    Nat Rev Drug Discov; 2015 Nov; 14(11):733-4. PubMed ID: 26388229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety biomarkers in preclinical development: translational potential.
    Sasseville VG; Mansfield KG; Brees DJ
    Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New NIH center broadens scope of translational research.
    Jenks S
    J Natl Cancer Inst; 2012 May; 104(10):728-31. PubMed ID: 22544941
    [No Abstract]   [Full Text] [Related]  

  • 6. Translating Alcohol Research: Opportunities and Challenges.
    Batman AM; Miles MF
    Alcohol Res; 2015; 37(1):7-14. PubMed ID: 26259085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease.
    Graham ML; Prescott MJ
    Eur J Pharmacol; 2015 Jul; 759():19-29. PubMed ID: 25823812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying translational science within the triangle of biomedicine.
    Weber GM
    J Transl Med; 2013 May; 11():126. PubMed ID: 23705970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positron emission tomography as a research tool for translational science].
    Nishimura S
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):136-40. PubMed ID: 23470478
    [No Abstract]   [Full Text] [Related]  

  • 10. Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development.
    Gibbs JP; Menon R; Kasichayanula S
    Clin Pharmacol Ther; 2018 Feb; 103(2):196-198. PubMed ID: 29105747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory science and the role of the regulator in biomedical innovation.
    Honig PK; Huang SM
    Clin Pharmacol Ther; 2012 Mar; 91(3):347-52. PubMed ID: 22343804
    [No Abstract]   [Full Text] [Related]  

  • 12. The new paradigm: from 'bench to bedside' to the translational research 'valleys of death'.
    Tugwell P; Knottnerus JA
    J Clin Epidemiol; 2015 Jul; 68(7):725-6. PubMed ID: 26047303
    [No Abstract]   [Full Text] [Related]  

  • 13. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
    Knoepfler PS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():192-6. PubMed ID: 25489841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovations driving biomarker evaluation and use.
    Wagner JA
    Biomark Med; 2010 Dec; 4(6):779-81. PubMed ID: 21133694
    [No Abstract]   [Full Text] [Related]  

  • 16. Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities.
    Beierlein JM; McNamee LM; Walsh MJ; Kaitin KI; DiMasi JA; Ledley FD
    Clin Ther; 2017 Jul; 39(7):1409-1425.e20. PubMed ID: 28652015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The principle of safety evaluation in medicinal drug - how can toxicology contribute to drug discovery and development as a multidisciplinary science?
    Horii I
    J Toxicol Sci; 2016; 41(Special):SP49-SP67. PubMed ID: 28250284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure drug discovery: scarred or ready for remodeling?
    Plump A; Madwed J
    J Mol Cell Cardiol; 2011 Oct; 51(4):444-8. PubMed ID: 21854785
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of translatability in drug discovery.
    Rezaee R; Abdollahi M
    Expert Opin Drug Discov; 2017 Mar; 12(3):237-239. PubMed ID: 28095719
    [No Abstract]   [Full Text] [Related]  

  • 20. Institutional profile: the Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
    Alfirevic A; Carr DF; Miyajima F; Pushpakom S; Sutton L; Jorgensen AL; Pirmohamed M
    Pharmacogenomics; 2013 Jun; 14(8):861-7. PubMed ID: 23746181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.